Dr. Subramanian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 1997 - 2000
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1994 - 1997
University of Michigan Medical SchoolClass of 1994
Certifications & Licensure
CA State Medical License 2013 - 2025
MD State Medical License 1997 - 2013
OH State Medical License 1996 - 1998
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 83 citationsCharacterizing the epidemiology of perioperative transfusion-associated circulatory overloadLeanne Clifford, Qing Jia, Hemang Yadav, Arun Subramanian, Gregory A. Wilson
Anesthesiology. 2015-01-01 - 68 citationsMELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.Aruna Subramanian, Mark S. Sulkowski, Burc Barin, Donald Stablein, Michael P. Curry
Gastroenterology. 2010-01-01 - 94 citationsPatients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: ...Karen B. Jacobson, Mallika Rao, Hector Bonilla, Aruna Subramanian, Isabelle Hack
Clinical Infectious Diseases. 2021-08-02
Journal Articles
- Impact of Pre-Transplant Donor BK Viruria in Kidney Transplant RecipientsAruna K Subramanian, Amy E Gallo, Jane C Tan, Gregory A Storch, Jason Kurzer, Benjamin A Pinsky, Waldo Concepcion, Susanna K Tan, Diane Alonso, The Journal of Infectious Diseases
Other
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19Aruna Subramanian, MD, The New England Journal of Medicine
https://www.doximity.com/articles/5d801831-c3b0-4ab4-9bf0-19bd673040b5
UpToDate, Wolters Kluwer Health - 2011-06-15
Authored Content
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19May 2020
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19May 2020
Press Mentions
What Does COVID-19 Do to Your Brain?February 7th, 2022- Antibodies in Blood Soon After COVID-19 Onset May Predict SeverityJanuary 18th, 2022
- Promising COVID Treatments Could Reach San Francisco Pharmacies by JanuaryDecember 3rd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
